By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cytokinetics, Inc. 

280 East Grand Avenue

South San Francisco  California  94080  U.S.A.
Phone: 650-624-3000 Fax: 650-624-3010


Drug Discovery

Company News
Cytokinetics (CYTK) To Ring The Nasdaq Stock Market Closing Bell 4/29/2016 10:37:16 AM
Cytokinetics (CYTK) Reports First Quarter 2016 Financial Results 4/29/2016 10:36:03 AM
Cytokinetics (CYTK) To Present At The 15th Annual Needham Healthcare Conference 4/6/2016 7:58:27 AM
Cytokinetics (CYTK) Announces Start Of Phase II Clinical Trial Of Omecamtiv Mecarbil In Japanese Subjects With Heart Failure 4/4/2016 8:33:17 AM
The ALS Association Awards Origent Data Sciences A Grant To Enable A Research Partnership With Cytokinetics (CYTK) 3/31/2016 10:56:20 AM
Origent And Cytokinetics (CYTK) Announce Research Collaboration On Predictive Analytics Model In ALS 3/31/2016 10:42:08 AM
Cytokinetics (CYTK) To Present At March Investor Conferences 3/2/2016 8:19:15 AM
Cytokinetics (CYTK)Joins Global Movement To Recognize International Rare Disease Day 2/29/2016 7:49:38 AM
Cytokinetics (CYTK) Reports Fourth Quarter 2015 Financial Results 2/17/2016 7:54:11 AM
Cytokinetics (CYTK) To Participate In Upcoming Investor Conferences 2/4/2016 7:51:20 AM